Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
PANEL DISCUSSION: Advancing bioanalytical method development and validation for small molecules 1 days 9 hours 1 mins 33 secs REGISTER NOW!

BZ 2024 wrapped

8 Jan 2025
Antibodies | ADCs Automation Biomarkers Cell and gene therapies Chromatography Clinical Drug development Expert opinion General interest Interviews MS (LC–MS/MS, HRMS, IMS) News Oligonucleotides

2024 was quite the year for the bioanalytical community. For this year’s summary, we’ve put together a new and exclusive feature to say thank you for your continued support as our audience. Check out our mood board below, offering a visual summary of the year’s top bioanalysis content.

Simply zoom in and click on your favorite features to find out more!

BZ 2024 WRAPPED (2)

Top content

  • Newborns and people with Alzheimer’s share a surprising biomarker
  • A pivotal peril of profoundly pernickety peptides

Related tags

2024 wrapped bioanalysis
Previous article

Related articles

29 NOV 2017 AN AUTHOR'S PERSPECTIVE
An author’s perspective
11 DEC 2023 JOURNAL ARTICLES
Challenges of implementing ultrahigh-throughput mass spectrometry in absorption, distribution, metabolism and excretion bioanalysis
8 FEB 2023 JOURNAL ARTICLES
Bioanalytical LC–MS/MS method for simultaneous estimation of atorvastatin, its major active metabolites and ezetimibe
23 JAN 2020 CONFERENCE REPORTS
Chinese New Year: exploring China’s bioanalytical landscape
7 JAN 2020 NEWS
The ABCs of bioanalysis – best of 2019
28 FEB 2020 NEWS
Frontage expand bioanalytical capabilities to support drug development, biomarker testing and high throughput sample management
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone